Abstract
Descriptions of extrapyramidal (EP) involvement in Pick’s disease (renamed recently as FTD) appeared 80 years ago. CBD pathology was confirmed as a common substrate for primary progressive aphasia (PPA). We suggested that CBD and PPA should be included with frontal lobe dementia as Pick complex. PSP was prototype for “subcortical dementia”, and aphasia and apraxia, considered unusual for PSP, are now seen as a rule. The overlap of PSP and CBD is considerable. We recently reviewed our cohort with EPS in FTD and identified 22 patients with the movement disorder as a first syndrome and another larger group of 48 patients who developed EPS after an initial onset with a cognitive disorder: aphasic, behavioral or both. All cognitive onset CBD/PSP patients and all but two with motor onset developed aphasia during the course of their illness. General cognitive and behavioral measures are similar for each presentation, but language scores are worse in cognitive onset cases, reflecting the frequency of aphasic presentations. Anomic patients become non-fluent, logopenic, agrammatic and mute. Using the Frontal Behavioral Inventory (FBI), a questionnaire specifically designed for the spectrum of apathy and disinhibition displayed by patients with FTD, we have documented the behavior change in CBD/PSP with motor and cognitive onsets. The significant personality changes consisted of apathy, disinhibition, perseveration and inattention, some of the core symptoms of FTD. In 18 autopsied cases, 15 had tau pathology. The overlap of CBD/PSP with PPA and bvFTD suggests a spectrum of related entities and predicts tau-positive pathology. Cross-sectional studies without significant follow-up may not observe the subsequent development language or behavior deficit, or the evolution from PPA and/or FTD-bv to CBD/PSP.
Similar content being viewed by others
References
Akelaitis AJ (1944) Atrophy of the basal ganglia in Pick’s disease. Arch Neurol Psychiatry 51:27–34
Albert ML, Feldman RG, Willis AL (1974) The “subcortical dementia” of progressive supranuclear palsy. J Neurol, Neurosurg Psychiatry 37:121–130
Bak TH, Crawford LM, Hearn VC et al (2005) Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 11:268–273
Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54(S5):15–19
Di Maria E, Tabaton M, Vigo T et al (2000) Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 47:374–377
Dickson DW (1999) Neuropathological differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:S6–S15
Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394–400
Esmonde T, Giles E, Xuereb J, Hodges J (1996) Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry 60:403–410
Feany MB, Mattiace LA, Dickson DW (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease and corticobasal degeneration. J Neuropathol Exp Neurol 55:53–67
Gibb WR, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112:1171–1192
Goulding PJ, Northen B, Snowden JS et al (1989) Progressive aphasia with right-sided extrapyramidal signs: another manifestation of localized cerebral atrophy. J Neurol Neurosurg Psychiatry 52:128–130
Grafman J, Litvan I, Gomez C, Chase TN (1990) Frontal lobe function in progressive supranuclear palsy. Arch Neurol 47:553–558
Grimes DA, Lang AE, Bergeron CB (1999) Dementia as the most common presentation of cortical-basal degeneration. Neurology 53:1969–1974
Houlden H, Baker M, Morris HR et al (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56:1702–1706
Josephs KA, Petersen RC, Knopman DS et al (2006a) Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66:41–48
Josephs KA, Duffy JR, Strand EA et al (2006b) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129:1385–1398
Keith-Rokosh J, Ang LC (2008) Progressive supranuclear palsy: a review of co-existing neurodegeneration. Can J Neurol Sci 35(5):602–608
Kertesz A, Hudson L, Mackenzie IRA, Munoz DG (1994) The pathology and nosology of primary progressive aphasia. Neurology 44:2065–2072
Kertesz A, Davidson W, Fox H (1997) Frontal behavioral inventory. Diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 24:29–36
Kertesz A, Martinez-Lage P, Davidson W, Munoz DG (2000) The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55:1368–1375
Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG (2005) The evolution and pathology of frontotemporal dementia. Brain 128:1996–2005
Kertesz A, Blair M, McMonagle P, Munoz D (2007) The diagnosis and course of frontotemporal dementia. Alzheimer Dis Assoc Disord 21:155–163
Knibb JA, Xuereb JH, Patterson K, Hodges JR (2006) Clinical and pathological characterization of progressive aphasia. Ann Neurol 59:156–165
Kovacs GG, Murrell JR, Horvath S et al. (2009) TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord 24(12):1843–1847.
Lang AE (1992) Cortico-basal ganglionic degeneration presenting with “progressive loss of speech output and orofacial dyspraxia. J Neurol Neurosurg Psychiatry 55:1101
Leiguarda R, Lees AJ, Merello M, Starkstein S, Marsden CD (1994) The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 57:455–459
Leiguarda RC, Merello M, Nouzeilles MI et al (2003) Limb-kinetic apraxia in corticobasal degeneration: clinical and kinematic features. Mov Disord 18:49–59
Ling H, O’Sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, Paviour DC, Lees AJ (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133(Pt 7):2045–2057
Lippa CF, Cohen R, Smith TW, Drachman DA (1991) Primary progressive aphasia with focal neuronal achromasia. Neurology 41:882–886
Litvan I, Mega MS, Cummings JL, Fairbanks L (1996) Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 47:1184–1189
Masellis M, Momeni P, Meschino W, Heffner R Jr, Elder J, Sato C, Liang Y, St George-Hyslop P, Hardy J, Bilbao J, Black S, Rogaeva E (2006) Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 129(Pt 11):3115–3123, Epub 2006 Oct 9
McMonagle P, Blair M, Kertesz A (2006a) Corticobasal degeneration and progressive aphasia. Neurology 67:1444–1451
McMonagle P, Deering F, Berliner Y, Kertesz A (2006b) The cognitive profile of posterior cortical atrophy. Neurology 66:331–338
Mendez MF (2000) Corticobasal ganglionic degeneration with Balint’s syndrome. J Neuropsychiatry Clin Neurosci 12:273–275
Mimura M, Oda T, Tsuchiya K et al (2001) Corticobasal degeneration presenting with nonfluent primary progressive aphasia: a clinicopathological study. J Neurol Sci 183:19–26
Munoz D (1998) The pathology of Pick complex. In: Kertesz A, Munoz D (eds) Pick’s disease and pick complex. Wiley-Liss, New York, pp 211–243
Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 51:1546–1554
Paviour DC, Lees AJ, Josephs KA et al. (2004) Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain 127(11)2441–2451.
Pharr V, Uttl B, Stark M, Litvan I, Fantie B, Grafman J (2001) Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 56:957–963
Pillon B, Blin J, Vidailhet M et al (1995) The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology 45:1477–1483
Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18:20–33
Ross OA, Whittle AJ, Cobb SA et al. (2006) Lrrk2 R1441 substitution and progressive supranuclear palsy. Neuropathol Appl Neurobiol 32(1):23–25.
Sha S, Hou C, Viskontas IV, Miller BL (2006) Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases? Nat Clin Pract Neurol 2(12):658–665
Soliveri P, Piacentini S, Girotti F (2005) Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 64:448–453
Spatt J, Bak T, Bozeat S, Patterson K, Hodges JR (2002) Apraxia, mechanical problem solving and semantic knowledge: contributions to object usage in corticobasal degeneration. J Neurol 249:601–608
Spina S, Murell JR, Huey ED et al. (2007) Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol 66(10):892–900.
Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. Arch Neurol 10:333–359.
Tang-Wai DF, Josephs KA, Boeve BF, Dickson DW, Parisi JE, Petersen RC (2003) Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology 61:1134–1137
Vidailhet M, Rivaud S, Guider-Khouja N, Pillon B, Bonner A-M, Gaymard B, Agid Y, Pierrot-Deseilligny C (1994) Eye movements in parkinsonian syndromes. Ann Neurol 35:420–426
Von Braunmuhl A (1930) Ueber Stammganglienveranderungen bei Pickscher Krankheit. Ztschr f d ges Neurol u Psychiat 124:214
Wider C, Dickson DW, Wszolek ZK (2010) Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener Dis 7(1–3)175–179.
Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T, Hasegawa M, Akiyama H, Sikkink S, Pickering-Brown S, Mann DM (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120(1):55–66, Epub 2010 May 30
Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VM, Schellenberg GD, Van Deerlin VM (2010) The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol 67(2):161–170
Zadikoff C, Lang AE (2005) Apraxia in movement disorders. Brain 128:1480–1497
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kertesz, A., McMonagle, P. & Jesso, S. Extrapyramidal Syndromes in Frontotemporal Degeneration. J Mol Neurosci 45, 336–342 (2011). https://doi.org/10.1007/s12031-011-9616-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-011-9616-1